SCLX Q4 2023 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena

SCLXScilex Holding Company

$73M

Q4 2023 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$13M+12.9% YoY

Gross Profit

$8M58.7% margin

Operating Income

-$18M-136.2% margin

Net Income

-$21M-159.0% margin

EPS (Diluted)

$-7.49

QoQ Revenue Growth

+33.1%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$6M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$101M

Total Liabilities

$274M

Stockholders' Equity

-$173M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$12M	+12.9%
Gross Profit	$8M	$7M	+6.8%
Operating Income	-$18M	-$20M	+7.1%
Net Income	-$21M	-$18M	-19.7%